ANCA-Associated Vasculitis: plasma exchange, glucocorticoids and avacopan - PWR (Nov 2024)

Michael Walsh, MD, PhD - Plasma exchange and glucocorticoids for ANCA-associated vasculitis: ...Подробнее

KDIGO 2024 Guideline on ANCA-Associated Vasculitis: Update on Current Management and TreatmentПодробнее

KDIGO 2024 ANCA Vasculitis Guideline: Reading Between the LinesПодробнее

Plasma exchange and glucocorticoids in severe ANCA- associated VasculitisПодробнее

ANCA-associated vasculitis : How to reduce glucocorticoids exposure ?Подробнее

Clinical Trials in Vasculitis: What's New, What's for YouПодробнее

Clinical Challenges in ANCA Associated VasculitisПодробнее

Plasma exchange and complement inhibitors in ANCA-associated vasculitis: Is there a role? - EnglishПодробнее

Trailer Avacopan in ANCA-Associated VasculitisПодробнее

Avacopan - C5a Receptor Inhibitor - in ANCA-Associated Vasculitis: Dr. Arthur KavanaughПодробнее

Current issues in ANCA associated vasculitisПодробнее

#40 Avacopan in ANCA-Associated Vasculitis, with Lorraine HarperПодробнее

ANCA Associated Vasculitis (Anti-Neutrophil Cytoplasmic Antibody) - Causes, Pathophysiology, TypesПодробнее

ANCA-associated #vasculitis can affect your major organs, skin, nerves and more.Подробнее

Steroid-Sparing Therapy for ANCA-Associated Vasculitis (AAV) #reelreviewПодробнее

Reducing Glucocorticoid Exposure in ANCA-Associated VasculitisПодробнее

The Future of Steroid UseПодробнее

Upcoming: What You Need to Know About Airway Issues with ANCA-associated vasculitisПодробнее